-
EP3000813
European procedure
Extract from the Register of European Patents
EP About this file: EP3000813
| EP3000813 - PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.10.2018 Database last updated on 19.10.2024 | |
| Former | The patent has been granted Status updated on 10.11.2017 | ||
| Former | Grant of patent is intended Status updated on 06.08.2017 | ||
| Former | Examination is in progress Status updated on 06.01.2017 | Most recent event Tooltip | 19.10.2018 | No opposition filed within time limit | published on 21.11.2018 [2018/47] | Applicant(s) | For all designated states GlaxoSmithKline LLC 251 Little Falls Drive Wilmington, DE 19808 / US | [2017/40] |
| Former [2016/20] | For all designated states GlaxoSmithKline LLC Corporation Service Company 2711 Centerville Road Suite 400 Wilmington DE 19808 / US | ||
| Former [2016/13] | For all designated states GlaxoSmithKline LLC Corporation Service Company 2711 Centreville Road Suite 400 Wilmington, Delaware 19808 / US | Inventor(s) | 01 /
BIGGADIKE, Keith GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | 02 /
COE, Diane Mary GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | 03 /
LEWELL, Xiao Qing GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | 04 /
MITCHELL, Charlotte Jane GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | 05 /
SMITH, Stephen Allan GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | 06 /
TRIVEDI, Naimisha GlaxoSmithKline Gunnels Wood Road Stevenage, Hertfordshire SG1 2NY / GB | [2016/13] | Representative(s) | Gladwin, Amanda Rachel GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [2016/13] | Application number, filing date | 15170143.0 | 07.08.2009 | [2016/13] | Priority number, date | US20080087777P | 11.08.2008 Original published format: US 87777 P | [2016/13] | Previously filed application, date | WO2009EP60265 | 07.08.2009 | [2016/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3000813 | Date: | 30.03.2016 | Language: | EN | [2016/13] | Type: | B1 Patent specification | No.: | EP3000813 | Date: | 13.12.2017 | Language: | EN | [2017/50] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.12.2015 | Classification | IPC: | C07D473/18, C07D473/16, A61K31/522, A61P37/00, A61P35/00 | [2016/13] | CPC: |
A61K31/522 (EP,KR,US);
C07D473/18 (EP,CN,KR,US);
A61K31/55 (EP,US);
A61K45/06 (US);
A61K9/0043 (US);
A61P29/00 (EP,US);
A61P31/00 (EP,US);
A61P35/00 (EP,US);
A61P37/00 (EP,US);
C07D473/16 (EP,CN,KR,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2016/13] | Extension states | AL | 01.06.2015 | BA | 01.06.2015 | RS | 01.06.2015 | Title | German: | PURINDERIVATE ZUR VERWENDUNG BEI DER BEHANDLUNG ALLERGISCHER, ENTZÜNDLICHER UND INFEKTIÖSER KRANKHEITEN | [2016/13] | English: | PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES | [2016/13] | French: | DÉRIVÉS PURINES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE MALADIES ALLERGIQUES, INFLAMMATOIRES ET INFECTIEUSES | [2016/13] | Examination procedure | 01.06.2015 | Examination requested [2016/13] | 17.08.2016 | Amendment by applicant (claims and/or description) | 09.01.2017 | Despatch of a communication from the examining division (Time limit: M04) | 04.04.2017 | Reply to a communication from the examining division | 07.08.2017 | Communication of intention to grant the patent | 02.11.2017 | Fee for grant paid | 02.11.2017 | Fee for publishing/printing paid | 02.11.2017 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP09781606.0 / EP2324026 | Divisional application(s) | EP17205469.4 / EP3336089 | Opposition(s) | 14.09.2018 | No opposition filed within time limit [2018/47] | Fees paid | Renewal fee | 01.06.2015 | Renewal fee patent year 03 | 01.06.2015 | Renewal fee patent year 04 | 01.06.2015 | Renewal fee patent year 05 | 01.06.2015 | Renewal fee patent year 06 | 01.06.2015 | Renewal fee patent year 07 | 05.08.2016 | Renewal fee patent year 08 | 10.08.2017 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2007142755 (UNIV CALIFORNIA [US], et al); | [A]EP1939198 (DAINIPPON SUMITOMO PHARMA CO [JP], et al); | [XDP]WO2008114008 (ASTRAZENECA AB [SE], et al) | by applicant | GB427857 | WO9834596 | EP1065213 | WO0147883 | WO0204425 | WO02057287 | WO02057245 | WO02074769 | WO03000254 | WO03007945 | WO03085375 | WO03095441 | WO2004037818 | WO2004054974 | WO2004055012 | WO2004055010 | WO2004055016 | WO2004055011 | WO2004054581 | WO2004064925 | WO2004065367 | WO2004074270 | WO2005014543 | WO2005044354 | US2005176701 | WO2005080388 | WO2005105761 | WO2006018725 | WO2006020082 | US2006045885 | WO2006045613 | WO2006122011 | WO2007138084 | WO2008114008 | GB20070023418 |